Date: 2 & 3 July 2018 Location: University of Manchester New solutions to Old Problems: ensuring sustainability of falls...Read more
Further Details Announced Concerning Latest SBRI Healthcare Funding Round and Briefing Sessions
SBRI Healthcare Call – Cancer: Screening, Earlier Diagnosis & Faster Diagnosis
SBRI Healthcare is an NHS England initiative led by the Academic Health Science Networks to develop technology solutions for known healthcare challenges. SBRI is actually a pre-competitive procurement programme designed to support innovative companies to develop solutions to unmet clinical need. The AHSNs support the Healthcare SBRI programme nationally and GMAHSN and Imperial College Health Partners (SW London AHSN) have co-sponsored this call.
Officially launched on the 25th July the next funding round on cancer focuses on finding innovative solutions with the ability to transform screening and facilitate both earlier and faster diagnosis of cancer. Applications are welcomed from companies with innovative solutions.
Cancer remains one of the public’s most feared illnesses, affecting more than one in three of us in our lifetimes. This reality means that most of us will face the anxiety of ourselves or a loved one receiving this diagnosis at some point.
We know that improving the ability to screen for and diagnose cancer earlier and faster – using tests that are accessible and minimally invasive, will enhance our already record high survival rates.
Since the early 1990s, UK incidence rates of all cancers have increased by 12%. In 2014, 357,000 new cases of cancer were diagnosed – the equivalent of 980 new diagnoses every day. By 2035, there are projected to be over 500,000 people diagnosed with cancer in the UK each year.
More than half of people receiving a cancer diagnosis will now live ten years or more. But there is much we could do to diagnose earlier and faster and so improve patient outcomes and long-term quality of life.
Successful applicants can receive up to £100,000 (incl. VAT) of funding for phase one (feasibility) and up to £1 million (incl. VAT) for phase two (development) for solutions that match the needs of the NHS.
There have been four briefing events scheduled for attendees to receive further details.The event was chaired by Linda with admin support from the Innovation Nexus team provided by TRUSTECH and our guest speakers were Mr Dave Shackley, Manchester Cancer Vanguard Medical Director, Professor John Radford, Research Director at the Christie, Gordon Barker, CEO, Microbiosensor, one of GM’s local companies based on University of Manchester IP who have been very successful getting SBRI contracts and have also been supported by the Innovation Nexus service and Joop Tannis, SBRI Director. We had approximately 30 delegates, several of whom were from outside GM.
For slides from the briefing session please click here: SBRI Cancer Briefing .
If you have any questions concerning the latest call or briefing session please call 01223 928040 or email email@example.com
Location: University of Liverpool Course dates: 24 – 28 September 2018 Course fee: £475, includes course materials, lunch and...Read more
A Digital Transformation event will take place in Liverpool on 27th June 2018 as part of the International Festival for Business. This...Read more
Wellcome’s Innovator Awards offer funding of up to £500,000 to support projects that focus on a range of areas,...Read more
Pupils from three Salford schools recently participated in a two-day event that aimed to inspire a new generation of...Read more
UK businesses are invited to apply to the Biomedical Catalyst for a share of up to £10 million to...Read more
Subscribe for Updates
Register to receive newsletters and information about new programmes and events.